FibroGen is the third Bay Area biomed to hike IPO target this week
October 31, 2014 at 15:24 PM EDT
Drug developer FibroGen has increased by 24 percent the amount it hopes to raise by going public, becoming the third Bay Area biotech-health company this week to increase their IPO targets...
